Style | Citing Format |
---|---|
MLA | S Yarahmadi SAHAR, et al.. "Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance." Molecular Biology Reports, vol. 52, no. 1, 2025, pp. -. |
APA | S Yarahmadi SAHAR, M Moradi Sarabi MOSTAFA, Z Abdolvahabi ZOHREH, Ss Ghorbanhosseini Seyedeh SARA, E Babaeenezhad ESMAEEL (2025). Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance. Molecular Biology Reports, 52(1), -. |
Chicago | S Yarahmadi SAHAR, M Moradi Sarabi MOSTAFA, Z Abdolvahabi ZOHREH, Ss Ghorbanhosseini Seyedeh SARA, E Babaeenezhad ESMAEEL. "Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance." Molecular Biology Reports 52, no. 1 (2025): -. |
Harvard | S Yarahmadi SAHAR et al. (2025) 'Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance', Molecular Biology Reports, 52(1), pp. -. |
Vancouver | S Yarahmadi SAHAR, M Moradi Sarabi MOSTAFA, Z Abdolvahabi ZOHREH, Ss Ghorbanhosseini Seyedeh SARA, E Babaeenezhad ESMAEEL. Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance. Molecular Biology Reports. 2025;52(1):-. |
BibTex | @article{ author = {S Yarahmadi SAHAR and M Moradi Sarabi MOSTAFA and Z Abdolvahabi ZOHREH and Ss Ghorbanhosseini Seyedeh SARA and E Babaeenezhad ESMAEEL}, title = {Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance}, journal = {Molecular Biology Reports}, volume = {52}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - S Yarahmadi SAHAR AU - M Moradi Sarabi MOSTAFA AU - Z Abdolvahabi ZOHREH AU - Ss Ghorbanhosseini Seyedeh SARA AU - E Babaeenezhad ESMAEEL TI - Implications of Mirna-590 Dysregulation in Digestive Tract Malignancies: Mechanistic Aspects and Clinical Significance JO - Molecular Biology Reports VL - 52 IS - 1 SP - EP - PY - 2025 ER - |